Trials (Dec 2020)

Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study

  • T. Vanassche,
  • M. M. Engelen,
  • Q. Van Thillo,
  • J. Wauters,
  • J. Gunst,
  • C. Wouters,
  • C. Vandenbriele,
  • S. Rex,
  • L. Liesenborghs,
  • A. Wilmer,
  • P. Meersseman,
  • G. Van den Berghe,
  • D. Dauwe,
  • G. Verbeke,
  • M. Thomeer,
  • T. Fivez,
  • D. Mesotten,
  • D. Ruttens,
  • L. Heytens,
  • I. Dapper,
  • S. Tuyls,
  • B. De Tavernier,
  • P. Verhamme,
  • DAWn consortium members

DOI
https://doi.org/10.1186/s13063-020-04991-y
Journal volume & issue
Vol. 21, no. 1
pp. 1 – 2

Abstract

Read online

An amendment to this paper has been published and can be accessed via the original article.